Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
1.340
-0.265 (-16.51%)
At close: Nov 12, 2026, 4:00 PM EST
1.280
-0.060 (-4.48%)
After-hours: Nov 12, 2026, 7:59 PM EST

Fate Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
43.9446.6336.0641.8761.33133.58
Short-Term Investments
95.19157.03243.01273.31374.89482.33
Cash & Short-Term Investments
139.13203.66279.07315.18436.23615.91
Cash Growth
-35.41%-27.02%-11.46%-27.75%-29.17%27.54%
Accounts Receivable
0.480.923.541.8338.488.68
Other Receivables
-0.72.10.90.81.1
Receivables
0.481.625.642.7339.289.78
Prepaid Expenses
4.653.437.213.6426.577.73
Total Current Assets
144.26208.7291.91331.54502.07633.41
Property, Plant & Equipment
88.9298.53110.89158.51176.09162.25
Long-Term Investments
-1.4727.660.984.94100.66
Long-Term Deferred Charges
----7.29.87
Other Long-Term Assets
5.110.2310.2415.1915.2615.26
Total Assets
238.28318.94440.69506.22705.56921.46

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
2.932.669.374.728.278.61
Accrued Expenses
15.1520.0221.3527.5153.9342.41
Current Portion of Leases
5.114.567.426.185.635.58
Current Unearned Revenue
-0.380.390.6942.2321.48
Other Current Liabilities
9.518.45--43.2
Total Current Liabilities
32.6936.0738.5239.09114.0581.28
Long-Term Leases
69.3873.2977.8597.36103.71109.24
Long-Term Unearned Revenue
-----27.12
Other Long-Term Liabilities
3.172.45.61.353.8624.97
Total Liabilities
105.24111.75121.97137.8221.62242.62

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.120.120.110.10.10.1
Additional Paid-In Capital
1,7591,7411,7161,5801,5361,449
Retained Earnings
-1,626-1,534-1,398-1,212-1,051-769.08
Comprehensive Income & Other
-0.160.120.270.02-1.85-0.76
Total Common Equity
133.03207.18318.72368.41483.94678.84
Shareholders' Equity
133.03207.18318.73368.42483.94678.84
Total Liabilities & Equity
238.28318.94440.69506.22705.56921.46

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
74.4977.8585.27103.54109.34114.82
Net Cash (Debt)
64.64125.81193.8211.64326.89501.09
Net Cash Growth
-52.53%-35.09%-8.43%-35.26%-34.77%29.95%
Net Cash Per Share
0.531.061.702.153.385.29
Filing Date Shares Outstanding
121.57116.26114.699.2498.1696.43
Total Common Shares Outstanding
121.53115.36113.9398.6397.2995.73
Working Capital
111.57172.63253.39292.45388.02552.13
Book Value Per Share
1.091.802.803.744.977.09
Tangible Book Value
133.03207.18318.72368.41483.94678.84
Tangible Book Value Per Share
1.091.802.803.744.977.09
Machinery
-29.6138.8583.2981.553.63
Leasehold Improvements
-62.3659.4959.0456.7852.95
SEC Filings: 10-K · 10-Q